Sébastien Plouffe
Net worth: 802 800 $ as of 31/05/2026
Net worth: 802 800 $ as of 31/05/2026
Sébastien Plouffe is the founder of Sediamek, Inc., founded in 2006, serving as President & Chief Executive Officer.
Mr. Plouffe is the founder of Defence Therapeutics Inc, founded in 2017, serving as President, Chief Executive Officer & Director.
Mr. Plouffe is also the founder of Chevalier Resources, Inc...
Mr. Plouffe currently serves as Director at Bullion Gold Resources Corp.
Former positions include President, Chief Executive Officer & Director at Affinor Growers, Inc. from 2014 to 2015; Director & Vice President-Public Relations at Vanstar Mining Resources, Inc. from 2019 to 2020; Secretary at X-Terra Resources Corp.
from 2007 to 2010; Head-Investor Relations at Anticus International Corp.; Vice President-Finance at Ximen Mining Corp.; Vice President at BMO Nesbitt Burns, Inc.; and Vice President at Canaccord Genuity Corp.
(Investment Management).
Education includes an undergraduate degree from HEC Montréal, conferred in 1994.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/04/2026 | 18,00,000 ( 2.38% ) | 802 800 $ | 31/05/2026 | |
| 11/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Founder | 18/07/2017 |
| BULLION GOLD RESOURCES CORP. | Director/Board Member | - |
Sediamek, Inc. | Chief Executive Officer | 01/01/2006 |
| Companies | Position | End |
|---|---|---|
| VANSTAR MINING RESOURCES INC. | Director/Board Member | 18/08/2020 |
| AFFINOR GROWERS INC. | Chief Executive Officer | 02/10/2015 |
Canaccord Genuity Corp. (Investment Management)
Canaccord Genuity Corp. (Investment Management) Investment ManagersFinance Profile Unavailable. | Corporate Officer/Principal | - |
BMO Nesbitt Burns, Inc.
BMO Nesbitt Burns, Inc. Financial ConglomeratesFinance Provides investment and financial advisory services | Corporate Officer/Principal | - |
Chevalier Resources, Inc.
Chevalier Resources, Inc. Other Metals/MineralsNon-Energy Minerals Mines for copper and cobalt | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
X-Terra Resources Corp.
X-Terra Resources Corp. Other Metals/MineralsNon-Energy Minerals Acquires, explores and develops mining properties | Non-Energy Minerals |
Affinor Growers, Inc.
Affinor Growers, Inc. Agricultural Commodities/MillingProcess Industries Grows and distributes medical marijuana | Process Industries |
Anticus International Corp.
Anticus International Corp. Food: Major DiversifiedConsumer Non-Durables Operates as a development stage company with interest to continue its world-wide license to convert waste materials from beer, soft drink and cheese manufacturers into yeast | Consumer Non-Durables |
Bullion Gold Resources Corp.
Bullion Gold Resources Corp. Precious MetalsNon-Energy Minerals Engages in the acquisition and exploration of mineral properties | Non-Energy Minerals |
Ximen Mining Corp.
Ximen Mining Corp. Precious MetalsNon-Energy Minerals Engages in exploration and development of mineral properties | Non-Energy Minerals |
Vanstar Mining Resources, Inc.
Vanstar Mining Resources, Inc. Precious MetalsNon-Energy Minerals Engages in the acquisition, exploration and development of mining & metal properties | Non-Energy Minerals |
BMO Nesbitt Burns, Inc.
BMO Nesbitt Burns, Inc. Financial ConglomeratesFinance Provides investment and financial advisory services | Finance |
HEC Montréal
HEC Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chevalier Resources, Inc.
Chevalier Resources, Inc. Other Metals/MineralsNon-Energy Minerals Mines for copper and cobalt | Non-Energy Minerals |
Canaccord Genuity Corp. (Investment Management)
Canaccord Genuity Corp. (Investment Management) Investment ManagersFinance Profile Unavailable. | Finance |
Sediamek, Inc. | |
Defence Therapeutics Inc
Defence Therapeutics Inc Pharmaceuticals: MajorHealth Technology Engages in the research and development of anti-body drug conjugates | Health Technology |
Select your edition
All financial news and data tailored to specific country editions